S.M. Qaim

ORCID: 0000-0003-0938-6782
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Radiopharmaceutical Chemistry and Applications
  • Nuclear Physics and Applications
  • Nuclear physics research studies
  • Nuclear reactor physics and engineering
  • Boron Compounds in Chemistry
  • Medical Imaging Techniques and Applications
  • Radioactive element chemistry and processing
  • Radioactive Decay and Measurement Techniques
  • Particle accelerators and beam dynamics
  • Muon and positron interactions and applications
  • Nuclear Materials and Properties
  • Astronomical and nuclear sciences
  • Chemical Synthesis and Characterization
  • Radiation Detection and Scintillator Technologies
  • Radiation Therapy and Dosimetry
  • X-ray Spectroscopy and Fluorescence Analysis
  • Radioactive contamination and transfer
  • Medical Imaging and Pathology Studies
  • Graphite, nuclear technology, radiation studies
  • Chemical Reactions and Isotopes
  • Fusion materials and technologies
  • Superconducting Materials and Applications
  • Mass Spectrometry Techniques and Applications
  • Radioactivity and Radon Measurements
  • Radiation Dose and Imaging

Forschungszentrum Jülich
2016-2025

Stadtwerke Jülich (Germany)
1990-2023

Advisory Board Company (United States)
2014-2016

University of Rajshahi
2013

University of Cologne
2000-2012

Ernst Ruska Centre
1991-2009

Hungarian Academy of Sciences
2000-2002

LVR-Klinik Köln
1990-1999

Lawrence Livermore National Security
1997-1999

Česká Zbrojovka (Czechia)
1997-1999

In the context of radiopharmacy and molecular imaging, concept theranostics entails a therapy-accompanying diagnosis with aim patient-specific treatment. Using adequate diagnostic radiopharmaceutical, disease state are verified for an individual patient. The other way around, it verifies that radiopharmaceutical in hand represents target-specific selective molecule: “best one” Transforming imaging into quantitative dosimetric information, optimum radioactivity (expressed maximum radiation...

10.3390/ph10020056 article EN cc-by Pharmaceuticals 2017-06-20

10.1007/s10967-018-6238-x article EN Journal of Radioanalytical and Nuclear Chemistry 2018-10-19

Abstract Medical radionuclide production technology is well established. Both reactors and cyclotrons are utilized for production; the positron emitters, however, produced exclusively using cyclotrons. A brief survey of methods most commonly used diagnostic therapeutic radionuclides given. The emerging considered in more detail. They comprise novel emitters emitting low-range electrons α-particles. possible alternative routes a few established radionuclides, like 68 Ga 99m Tc, discussed....

10.1524/ract.2012.1966 article EN cc-by-nc Radiochimica Acta 2012-07-30

The nuclear data required for the production and endotherapeutic application of radionuclides are outlined. three types therapeutic radionuclides, viz. β - -emitters, α-emitters Auger electron emitters, considered role some + -emitters in therapy planning is discussed. status available reviewed.

10.1524/ract.2001.89.4-5.297 article EN Radiochimica Acta 2001-04-01

Article Excitation Functions of (p,xn)-Reactions on natNi and Highly Enriched 62Ni: Possibility Production Medically Important Radioisotope 62Cu at a Small Cyclotron was published February 1, 1992 in the journal Radiochimica Acta (volume 57, issue 1).

10.1524/ract.1992.57.1.1 article EN Radiochimica Acta 1992-02-01

Abstract Alpha particles exhibit three important characteristics: scattering, ionisation and activation. This article briefly discusses those properties outlines their major applications. Among others, α -particles are used in elemental analysis, investigation improvement of materials properties, nuclear reaction studies medical radionuclide production. The latter two topics, dealing with activation target materials, treated some detail this paper. Measurements excitation functions -particle...

10.1515/ract-2015-2566 article EN Radiochimica Acta 2016-06-08

10.1007/s10967-019-06797-y article EN Journal of Radioanalytical and Nuclear Chemistry 2019-09-26

Abstract Extensive nuclear data studies have been carried out over the last 30 years in context of accelerator-based production radionuclides, especially at energies below MeV, and achieved database is fairly good. Yet there are some deficiencies or new needs data. Those generally associated with emerging clinical applications e.g. theranostic approach, bimodal imaging, radioimmuno-therapy, etc. This article gives an overview on-going research utilizing charged-particle accelerators four...

10.1007/s10967-023-09285-6 article EN cc-by Journal of Radioanalytical and Nuclear Chemistry 2024-01-08

10.1524/ract.1995.7071.special-issue.249 article EN Radiochimica Acta 1995-12-01

The relatively long-lived positron emitters 64 Cu ( t 1/2 = 12.7 h), 76 Br 16.2 h) and 124 I 4.18 d) are finding increasing applications in emission tomography (PET). For precise determination of their intensities, each radionuclide was prepared via a charged particle induced reaction “no-carrier-added” form with high radionuclidic purity. It then subjected to γ -ray X-ray spectroscopy as well anticoincidence beta γγ -coincidence counting. intensities measured were: (17.8 ± 0.4)%, (58.2...

10.1524/ract.2007.95.2.67 article EN Radiochimica Acta 2007-01-29

Abstract In molecular imaging, the importance of novel longer lived positron emitters, also termed as non-standard or innovative PET radionuclides, has been constantly increasing, especially because they allow studies on slow metabolic processes and in some cases furnish possibility quantification radiation dose internal radiotherapy. Considerable efforts have invested worldwide about 25 emitters developed. Those relate to interdisciplinary dealing with basic nuclear data, high current...

10.1524/ract.2011.1870 article EN Radiochimica Acta 2011-08-04

Abstract A very brief overview of the hitherto investigated production routes 86g Y is given, and a comparative analysis its via two low-energy reactions, namely (p,n) (d,2n) on 96.4 % enriched 86 Sr as target material, presented. Based our recent cross-section measurements, calculated yields reactions were compared, levels co-produced isotopic impurities estimated. At medical cyclotrons ( E p < 20 MeV; d 10 MeV) use reaction superior, both in terms yield radionuclidic impurities....

10.1515/ract-2024-0375 article EN Radiochimica Acta 2025-03-12
Coming Soon ...